Acquisition leverage Leverage ResMed’s 2021 acquisition of Ectosense to explore co-marketing and bundled sleep diagnostic solutions, highlighting continuity of NightOwl tech and potential integration with ResMed’s product ecosystem.

Sleep tech demand Target the growing home sleep testing market, emphasizing at‑home, finger‑based diagnostic devices and cloud connectivity to appeal to sleep clinics, primary care partners, and telemedicine platforms seeking convenient, scalable solutions.

Small biosecurity Position Ectosense’s HIPAA‑compliant tech stack and cloud services as a buying criterion for healthcare organizations prioritizing data privacy, interoperability, and secure patient data handling.

Funding to traction Note earlier seed funding and ambitious scale potential; use this to pitch partnerships or pilot programs with mid‑market hospitals or digital health platforms seeking innovative sleep diagnostics with growth upside.

Strategic partnerships Explore collaboration with MedCall Advisors and similar channel partners to expand distribution, increase adoption in Europe and North America, and accelerate go‑to‑market for home sleep testing devices.